IOL Chemicals & Pharmaceuticals
97.53
-0.52(-0.53%)
Market Cap₹2,878.00 Cr
PE Ratio27.23
IndustryHealthcare
Company Performance:
1D-0.53%
1M-15.95%
6M+46.16%
1Y+15.22%
5Y-27.63%
View Company Insightsright
More news about IOL Chemicals & Pharmaceuticals
16May 25
IOL Chemicals: Q4 Net Profit Rises 13.7%, Margins Expand
IOL Chemicals and Pharmaceuticals Ltd announced impressive Q4 financial results. EBITDA increased by 28.5% to ₹62.60 crore, with EBITDA margin improving to 11.80%. Net profit rose by 13.7% to ₹31.42 crore, while revenue grew by 4.7% to ₹527.70 crore. The company demonstrated improved operational efficiency and effective cost management.
24Mar 25
IOL Chemicals and Pharma Boosts Production Capacity with New Paracetamol Unit and Clopidogrel Expansion
IOL Chemicals and Pharmaceuticals Limited (IOLCP) has significantly expanded its production capabilities. The company launched a new Paracetamol production unit with a capacity of 10,800 MTPA, increasing total capacity to 14,400 MTPA. IOLCP also expanded its Clopidogrel Bisulphate manufacturing capacity from 180 MTPA to 240 MTPA. The Paracetamol expansion cost Rs 155.51 crore, while the Clopidogrel expansion required Rs 7.87 crore, both funded through internal accruals. The new Paracetamol unit includes backward integration with in-house production of key intermediates.
1 Year Returns:+15.22%
Industry Peers
Sun Pharmaceutical
1,679.10
(+1.21%)
Divis Laboratories
6,621.50
(+0.32%)
Cipla
1,577.60
(+0.52%)
Torrent Pharmaceuticals
3,584.30
(+1.43%)
Dr Reddys Laboratories
1,255.90
(+1.27%)
Mankind Pharma
2,476.60
(+0.87%)
Zydus Life Science
987.65
(+0.31%)
Lupin
1,940.00
(-0.57%)
Alkem Laboratories
5,581.50
(+1.04%)
Aurobindo Pharma
1,101.00
(-0.48%)